Reducing patient risk for human papillomavirus infection and cervical cancer

Jennifer Herbert, Janis Strickland Coffin

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


The majority of cervical cancers result when the human papillomavirus (HPV) is transmitted from a man to a woman during vaginal intercourse. Several factors, including vaginal intercourse at an early age or with multiple sex partners, place women at increased risk for infection with HPV. It is important for physicians to be aware of these risk factors and to screen for them in all of their female patients. It is also important for physicians to be familiar with the new HPV vaccinations that are becoming available, such as Gardasil, which in June 2006 became the first vaccine approved by the US Food and Drug Administration to protect patients against cervical cancer. The widespread use of routine HPV screening and cervical cancer vaccines can be expected to decrease the incidence of new HPV infection and cervical cancer worldwide.

Original languageEnglish (US)
Pages (from-to)65-70
Number of pages6
JournalJournal of the American Osteopathic Association
Issue number2
StatePublished - Feb 1 2008

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Reducing patient risk for human papillomavirus infection and cervical cancer'. Together they form a unique fingerprint.

Cite this